|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 31/40 A61K 31/42 C07D 401/00 C07D 403/00 C07D 413/00 |
| (11) | Number of the document | 3264 |
| (13) | Kind of document | B |
| (21) | Application number | IP419 |
| (22) | Date of filing the application | 1993-03-15 |
| (41) | Date of publication of the application | 1994-11-25 |
| (45) | Date of publication of patent | 1995-05-25 |
| (30) | Number | Date | Country code |
| 9012672 | 1990-06-07 | GB | |
| 9102182 | 1991-02-01 | GB | |
| PCT/GB91/00908 | 1991-06-06 | WO |
| (71) |
THE WELLCOME FOUNDATION LIMITED,
Unicorn House, 160 Euston Road, London NW1 2BP,
GB
|
| (72) |
Alan Duncan ROBERTSON, GB
Alan Peter HILL, GB Robert Charles GLEN, GB Graeme Richard MARTIN, GB |
| (73) |
AstraZeneca AB,
15185 Sodertalje,
SE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | THERAPEUTIC HETEROCYCLIC COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2012-02-28 | 20 | 1200.00 LTL |
| Patent expired | ||
| Invalidation date | 2013-03-15 |